Thyrocare Q1 FY26 PBT rises 50.5% YoY to ₹50.48 crore; revenue, EBITDA, and margins improve significantly amid rising operating expenses.

• Total expenses rose 16.45% YoY in Q1 to ₹147.45 crore, with employee benefits and materials costs up 14.9% and 24.1%.
• Diagnostic Testing Services revenue grew 24.52% to ₹178.33 crore in Q1, while Imaging Services revenue rose 7.67% to ₹14.04 crore.
• EBITDA increased 37% YoY to ₹57.46 crore in Q1 FY26, the margin improved to 30%, and Vikram Gupta was appointed the new CFO.